E1: A method of delivering a medication aerosol for treating sinusitis or rhinitis, and related neurological disorders of the cranial cavity and facial tissue.

E2: The filter comprises pores; the medication aerosol and the liquid composition do not contain a surfactant and the liquid composition comprises one or more compounds selected from the group consisting of antifungals, leukotriene antagonists, anti-TNF compounds, antihistamines, mucolytics, estrogen and progesterone. The liquid composition also comprises an antibiotic, and wherein the antibiotic is selected from the group of antibiotic classes consisting of: cephalosporins, penicillins, aminoglycocides, quinolones, tetracyclines and macrolides and also antivirals selected from the group consisting of oseltamivir, acyclovir and rimantadine. Further includes, montelukast and zafirlukast, anti-inflammatory is selected from the group consisting of budesonide, betamethasone and mometasone, mucolytic is selected from the group consisting of acetylcysteine and dornase alpha.

E3: The medication aerosol is made using a method comprising creating the medication aerosol by passing a liquid composition through a filter, and wherein the filter comprises pores, thereby forming the aerosol; and the medication aerosol and the liquid composition do not contain a surfactant.